LAX.SH
ORTIN GLOBAL LIMITED·Healthcare Companies·Pharmaceuticals & Biotechnology Companies
Price
15.89
-0.38%52W Range
Market Cap
₹12.92 Cr
Traded: ₹0.00 Cr (0.03%) 0.0x
Free Float: ₹12.20 Cr (0.04% of FF traded)
Volume · 60D trend
2.86 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | -- | -- |
| ROE | -- | -- | -- | -- | -- | -- |
| Return | +2.0% | -10.0% | -2.0% | +57.0% | -- | Accelerating |
| Profit | -- | -- | -- | -- | -- | -- |
Quarterly Results
Jun 2012
Mar 2012
Jun 2011
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2012 | Mar 2012 | Jun 2011 | |
|---|---|---|---|
| Sales | 16 | 20 | 20 |
| Expenses | 14 | 21 | 17 |
| Operating Profit | 2 | -1 | 3 |
| OPM % | 13.1% | -5.1% | 13.5% |
| Other Income | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit Before Tax | 1 | -2 | 2 |
| Tax % | 33.3% | -11.9% | 33.3% |
| Net Profit | 0 | -2 | 1 |
| Exceptional Items | -- | -- | -- |
| EPS (Rs) | 0.3 | -1.1 | 3.2 |
| Sales Growth (YoY) | -19.6% | -- | -- |
| Sales Growth (QoQ) | -19.4% | -0.2% | -- |
| OP Growth (YoY) | -22.4% | -- | -- |
| OP Growth (QoQ) | 308.0% | -- | -- |
| Profit Growth (YoY) | -63.0% | -- | -- |
| EPS Growth (YoY) | -92.0% | -- | -- |
| EPS Growth (QoQ) | 122.8% | -135.2% | -- |
| OP Margin | 13.1% | -5.1% | 13.5% |
| Net Margin | 2.8% | -9.7% | 6.1% |
| Material Cost % | 71.0% | 82.0% | 75.0% |
| Employee Cost % | 3.0% | 5.0% | 3.0% |
| P/S | -- | -- | -- |
| P/E | -- | -- | -- |
| P/B | -- | -- | -- |
Exchange Filings
50Outcome of Board Meeting held on 14.08.2026
Unaudited Financial Results for the quarter ended 30.06.2026
Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Offer Post-Offer Advertisement under Regulation 18(12) in terms of the Securities And Exchange ....
Closure of trading window for Unaudited Financial Results for the quarter ending 30.06.2026
Audited Financial Results along with Audit Report for the Quarter and Year ended 31.03.2026
Outcome of Board Meeting held on 30.05.2026
Annual Secretarial Compliance Report for the Year ended 31.03.2026
Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. Audited standalone financial ....
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has informed BSE as under :<BR><BR>"With reference to the captioned subject, Public Announcement dated February 10, 2026, Detailed ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Closure of trading window for audited financial results for quarter and year ending 31.03.2026.
Rarever Financial Advisors Pvt. Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of ....
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh Gadalay & PACs
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Ortin Global Ltd ("Target Company").
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 4 read with Regulations 13(4), 14(3) and 15(2) ....
Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31.12.2025
Outcome of Board Meeting held on 14.02.2026
Unaudited Financial Results for the quarter ended 31.12.2025
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the Public Announcement dated February 10, 2026 for the attention of the public ....
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under regulations 3(1) and 4 read with Regulation 13, 14 and 15(1) and other ....
Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....
Compliance Certificate under Reg. 74(5) of SEBI (DP) regulations, 2018
Closure of trading window for unaudited financial results for the quarter ending 31.12.2025
Outcome of Board meeting held on 14.11.2025
Unaudited financial results for the quarter and half year ended 30.09.2025
Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. Unaudited financial results ....
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Scrutinizer''s Report and Voting Results for the 38th AGM of the company held on 30.09.2025
Outcome of AGM held on 30.09.2025
Closure of trading window for unaudited financial results for the quarter and half year ending 30.09.2025.
38th Annual Report of the Company for the FY 2024-25
Notice of 38th AGM of the Company scheduled to be held on 30.09.2025
Resignation of Mr. Sashikant Shankarrao Igave as Non-Executive Non-Independent Director w.e.f. 08.09.2025
Outcome of Board meeting held on 05.09.2025
Scrutinizer''s Report for the 1st EGM for FY 2025-26
Outcome of 1st Extra Ordinary general meeting for the FY 2025-26
Newspaper Publication of Unaudited financial Results for the quarter ended 30.06.2025
Unaudited Financial Results for the quarter ended 30.06.2025
Unaudited Financial Results for the quarter ended 30.06.2025
Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Un-audited Financial Results for ....
Clarification on Price Movement with reference to BSE email dated 31.07.2025
The Exchange has sought clarification from Ortin Global Ltd on July 31, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Compliance Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018
Intimation of set up of corporate office address
Resignation of Executive and Non-Executive Directors